BOYEN THERAPEUTICS, INC.
Area: Pharmaceutical and Medical Devices
Booth No:
L225
Website: http://www.boyentherapeutics.com/
Exhibitor Profile
BoYen Therapeutics Inc. has a proprietary prodrug platform that enables chemosynthesis modifications to create patentable new drug candidates, for treatment of new indications.
Our pipeline comes with immense commercial values. Currently, two candidates are under development. BY-101 is an USFDA designated orphan drug with a 7-year marketing exclusivity; it is intended for the treatment of acute myeloid leukemia (AML). BYT-1007 is patented drug candidate for the treatment of multiple sclerosis.
Brands
BOYEN THERAPEUTICS
Exhibit Products
Exhibitors you may be interested in
Highest Rated
-
SUNWAY SCIENTIFIC CORPORATION
-
MINOGA INDUSTRIAL CO., LTD.
-
DEPARTMENT OF LIFE SCIENCES, NATIONAL CHUNG HSING UNIVERSITY
-
PHARMAESSENTIA CORP.
-
NATIONAL TAIWAN UNIVERSITY
-
FORESEE PHARMACEUTICALS CO., LTD.
-
FORMOSA PHARMACEUTICALS , INC
-
TCI CO., LTD.
-
INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
-
MYCOMAGIC BIOTECHNOLOGY CO., LTD.
-
QUARK BIOSCIENCES TAIWAN, INC.
-
GOLDEN BIOTECHNOLOGY CORP.
-
TSH BIOPHARM
-
COLD SPRING BIOTECH CORP.
-
ENERGENESIS BIOMEDICAL CO., LTD.
-
HANCHORBIO INC.
-
ANN TONG INDUSTRIAL CO.,LTD
-
CATCHGENE CO., LTD.
-
DEVELOPMENT CENTER FOR BIOTECHNOLOGY
-
TAIPEI MEDICAL UNIVERSITY
-
LUKAS BIOMEDICAL INC.
-
TAIMED BIOLOGICS INC.
-
AGILENT TECHNOLOGIES TAIWAN LTD.
-
BESTGEN BIOTECH CORP.
-
EFFICIENT PHARMA MANAGEMENT CORP.
-
ADIMMUNE CORPORATION
-
FORMOSA LABORATORIES, INC.
-
OME TECHNOLOGY CO., LTD.
-
BOYEN THERAPEUTICS, INC.
-
ZAX CO., LTD.
back